Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mechanical Ventilation I: Indication and Settings

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interpretable Multimodal AI to Predict the Presence of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Cardiac Sarcoidosis Patients.

Circulation. Arrhythmia and electrophysiology·2026

Same author

Can Systemic Sarcoidosis and Genetic Cardiomyopathy Coexist?

JACC. Case reports·2026

Same author

Rising Up to Meet our Patients on their Diagnostic and Treatment Odysseys.

Journal of cardiac failure·2026

Same author

Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS).

Journal of cardiac failure·2026

Same author

Bridging the Divide: Divergent Diagnostic Philosophies and Practice Pathways for Cardiac Sarcoidosis between Japan and North America.

Journal of cardiac failure·2026

Same author

Cardiac sarcoidosis: An algorithmic approach to diagnosis and treatment of the "Great Mimicker".

Best practice & research. Clinical rheumatology·2026

Same journal

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026

Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026

Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026

Same journal

Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunities.

Heart failure reviews·2026

Same journal

Correction to: Left atrial shunting devices: why, what, how, and… when?

Heart failure reviews·2026

Same journal

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Heart failure reviews·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 22, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Patient selection for mechanical circulatory support.

Nisha A Gilotra¹, Stuart D Russell

¹Division of Cardiology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA.

Heart Failure Reviews

|May 1, 2012

Summary

This summary is machine-generated.

Left ventricular assist devices (LVADs) improve heart failure outcomes. Proper patient selection and pre-operative therapy are crucial for optimizing results in advanced heart failure patients.

Related Experiment Videos

Last Updated: May 22, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

Cardiology
Medical Devices
Heart Failure Management

Background:

Heart failure (HF) remains a significant cause of morbidity and mortality.
Left ventricular assist devices (LVADs) have emerged as a vital therapy over the last decade.
LVADs have demonstrated improvements in survival and quality of life for HF patients.

Purpose of the Study:

To review the indications for considering LVAD therapy.
To discuss pre-operative considerations and therapies to enhance post-insertion outcomes.
To emphasize the importance of optimal patient selection timing for LVAD implantation.

Main Methods:

Review of current literature on LVAD therapy indications.
Analysis of pre-operative management strategies for LVAD candidates.
Discussion of factors influencing post-LVAD outcomes.

Main Results:

LVADs offer significant benefits in selected heart failure patients.
Patient selection and timing of LVAD implantation are critical for success.
Pre-operative optimization can potentially improve post-implantation outcomes.

Conclusions:

LVAD therapy is a valuable treatment option for advanced heart failure.
Careful patient selection and timely intervention are paramount.
Pre-operative optimization strategies warrant further investigation to maximize LVAD benefits.